HCV治愈后肝硬化患者即将发生HCC诊断时呈现自然杀伤细胞特征
本研究在8个队列中分析HCV治愈后肝硬化患者NK细胞特征,发现进展为HCC者NK细胞上TIM-3和CD38持续高表达,且随时间的推移与无HCC者的NK细胞特征差异增大;该特征可能作为评估HCC发生风险的工具。
要点
- HCV治愈后肝硬化患者仍存在HCC风险,NK细胞特征可提示风险。
- TIM-3hi与CD38+持续共表达是HCV相关HCC发生的早期指标。
- NK细胞谱分析可能有助于及时评估HCV治愈后肝硬化患者的HCC风险。
核心结论
- HCV相关HCC的发生对NK细胞印记有深远影响,TIM-3hi与CD38+持续共表达是HCV相关HCC发生的早期指标。
研究设计与样本
- 研究调查了覆盖HCC发生、诊断和发病时间跨度的8个队列中的NK细胞特征和功能。
主要发现
- HCV治愈后肝硬化患者中,发生HCC者与未发生HCC者的NK细胞特征随时间推移差异增大。
- 发生HCC者NK细胞上TIM-3和CD38持续高频率表达,健康对照中基本缺失,且与HCC发生高概率相关。
- 功能实验显示这些NK细胞具有强效细胞毒性特征。
- 未发生HCC者的NK细胞特征随时间推移与健康对照趋同。
- 单细胞测序显示这些细胞在肝组织和浸润边缘频率高,在肿瘤中频率明显较低。
临床怎么用
- NK细胞谱分析可能作为快速、有价值的工具,及时评估HCV治愈后肝硬化患者的HCC发生风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The risk of developing HCC in chronically infected patients with AQ2 HCV with liver cirrhosis is significantly elevated. This risk remains high even after a sustained virological response with direct-acting antivirals. To date, disease-associated signatures of NK cells indicating HCC development are unclear. APPROACH AND RESULTS: This study investigated NK cell signatures and functions in 8 cohorts covering the time span of HCC development, diagnosis, and onset. In-depth analysis of NK cell profiles from patients with cirrhosis who developed HCC (HCV-HCC) after sustained virological response compared with those who remained tumor-free (HCV-noHCC) revealed increasingly dissimilar NK cell signatures over time. We identified expression patterns with persistently high frequencies of TIM-3 and CD38 on NK cells that were largely absent in healthy controls and were associated with a high probability of HCC development. Functional assays revealed that the NK cells had potent cytotoxic features. In contrast to HCV-HCC, the signature of HCV-noHCC converged with the signature found in healthy controls over time. Regarding tissue distribution, single-cell sequencing showed high frequencies of these cells in liver tissue and the invasive margin but markedly lower frequencies in tumors. CONCLUSIONS: We show that HCV-related HCC development has profound effects on the imprint of NK cells. Persistent co-expression of TIM-3hi and CD38 + on NK cells is an early indicator for HCV-related HCC development. We propose that the profiling of NK cells may be a rapid and valuable tool to assess the risk of HCC development in a timely manner in patients with cirrhosis after HCV cure.
引用
- Engelskircher SA, Chen PC, Strunz B, et al. Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature. Hepatology. 2024. PMID: 38381525. doi:10.1097/HEP.0000000000000804
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。